68462-405Level 3
ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE (ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE)
**Product type:** Human Prescription Drug
**Active ingredient:** ASPIRIN; DIPYRIDAMOLE
**Strength:** 25; 200 mg/1; mg/1
**Dosage form:** Capsule
**Route:** Oral
**Labeler:** Glenmark Pharmaceuticals Inc., USA
**Marketing category:** ANDA (ANDA210318)
**Pharmacologic class:** Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Platelet Aggregation Inhibitor [EPC]
GET
/api/v1/systems/ndc_fda/nodes/68462-405Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.